Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00251589
Status:
TERMINATED
Last Update Posted:
2015-03-06
First Post:
2005-11-07
Brief Title:
A Phase III Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With RelapsedRefractory Non-Small-Cell Lung Cancer 0683-025
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC